Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices (IPANEMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02838368
Recruitment Status : Completed
First Posted : July 20, 2016
Last Update Posted : February 25, 2019
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Tahseen Mozaffar, University of California, Irvine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2018
Actual Study Completion Date : December 1, 2018
Publications:
Hirschhorn R, Reuser AJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet A, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001:3389-420.